Regeneron Pharmaceuticals, Inc. (REGN)
779.42
-5.55
(-0.71%)
USD |
NASDAQ |
Dec 29, 12:56
Regeneron Pharmaceuticals Shareholders Equity (Quarterly): 30.96B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Gilead Sciences, Inc. | 21.54B |
| Johnson & Johnson | 79.28B |
| Eli Lilly & Co. | 23.79B |
| Merck & Co., Inc. | 51.85B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.17B |
| Total Liabilities (Quarterly) | 9.212B |
| Debt to Equity Ratio | 0.0874 |
| Current Ratio | 4.063 |
| Net Debt Paydown Yield | -0.00% |